Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 4 min 26 sec ago

Expanding Orthopedics Inc. Announces that Mr. Dale Binke Joins Company's Management as Vice President of US Sales

Tue, 04/12/2016 - 15:55
Industry veteran to join EOI to lead and develop growing US Sales OR AKIVA, Israel, April 12, 2016 -- (Healthcare Sales & Marketing Network) -- Expanding Orthopedics Inc. (EOI), a privately held medical device company focused on developing and commerci...
Devices, Orthopaedic, Neurosurgery, Personnel
Expanding Orthopedics

AQUACEL(R) Foam Pro Dressing to be featured at Spring SAWC

Tue, 04/12/2016 - 15:52
Newest addition to AQUACEL®portfolio uses Hydrofiber®Technology to protect sacral skin from breakdown LUXEMBOURG, April 12, 2016 -- (Healthcare Sales & Marketing Network) -- ConvaTec, a leading global medical products and technologies company, ...
Devices, Wound Care
ConvaTec, AQUACEL

iSTAR Medical Secures €10 Million Financing

Tue, 04/12/2016 - 13:17
Funding Supports Product Development and CE-marking clinical study for Breakthrough Glaucoma Implant WAVRE, Belgium, April 12, 2016 -- (Healthcare Sales & Marketing Network) -- iSTAR Medical SA, a private medical device company developing novel ophthal...
Devices, Ophthalmology, Venture Capital
iSTAR Medical, MINIject, MIGS device

Autonomic Technologies Appoints Niamh Pellegrini as President and Chief Executive Officer

Tue, 04/12/2016 - 13:06
REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Autonomic Technologies, Inc. (ATI) today announced the appointment of Niamh Pellegrini to the position of President and Chief Executive Officer and member of its board of directors. In this role...
Devices, Neurology, Personnel
Autonomic Technologies, Pulsante Microstimulator, cluster headache

AtriCure Announces 510(k) Clearance for the cryoFORM(TM) Cryoablation Probe

Tue, 04/12/2016 - 12:59
Clearance brings an even more flexible probe to the U.S. market for use in a variety of surgical interventions to treat cardiac arrhythmias. Product was launched in Europe in October 2015 MASON, Ohio--(Healthcare Sales & Marketing Network)--AtriCure,...
Devices, Interventional, Cardiology, FDA
AtriCure, atrial fibrillation, cryoFORM, cryoablation

Elite Pharmaceuticals Announces Changes to their Board of Directors

Tue, 04/12/2016 - 12:53
Gene Pfeifer Joins Elite’s Board NORTHVALE, N.J., April 12, 2016 -- (Healthcare Sales & Marketing Network) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (ELTP) announced today that its Board of Directors has appointed Eugene P...
Biopharmaceuticals, Personnel
Elite Pharmaceuticals

Bioness(R) Releases The Second Gernation Of The Bioness Integrated Therapy System (BITS(R))

Mon, 04/11/2016 - 19:57
Company rebuilt the second generation platform from the ground up, integrating feedback from customers to develop new treatment therapy programs and outcome measures VALENCIA, Calif., April 11, 2016 -- (Healthcare Sales & Marketing Network) -- Bioness ...
Devices, Product Launch
Bioness, Bioness Integrated Therapy System, rehabilitation, physical therapy

Beyhan Zaim appointed Vice President Commercial Development and Alzheimer's Disease Global Lead, Neurology Business Group at Eisai Inc.

Mon, 04/11/2016 - 19:51
WOODCLIFF LAKE, N.J., April 11, 2016 -- (Healthcare Sales & Marketing Network) -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announced the immediate appointment of Beyhan Zaim as Vice President Commercial Development & Alzhei...
Biopharmaceuticals, Neurology, Personnel
Eisai, Alzheimer's Disease

Adapt Pharma Names Mike Kelly President of U.S. Operations

Mon, 04/11/2016 - 19:48
Contributing Over 25 Years of Pharmaceutical Expertise to Adapt Executive Team DUBLIN, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- Adapt Pharma, (www.adaptpharma.com) announced today that Mike Kelly has been appointed as President of U....
Biopharmaceuticals, Personnel
Adapt Pharma, NARCAN, naloxone

Stryker Acquires SafeWire Product Portfolio for Use in Minimally-Invasive (MIS) Spine Procedures

Mon, 04/11/2016 - 19:46
Technology Used with Stryker’s Percutaneous ES2 Spinal Fixation System & LITe (Less Invasive Technologies) Procedural Solutions ALLENDALE, N.J.--(Healthcare Sales & Marketing Network)--Stryker’s Spine division today announced the acquisition of the Safe...
Devices, Orthopaedic, Neurosurgery, Acquisitions
Stryker, SafeWire, Y-Wire, Tiger Jamshidi Needle

St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy

Mon, 04/11/2016 - 14:43
Availability of the dorsal root ganglion (DRG) therapy represents an important milestone in the treatment of chronic intractable pain conditions due to complex regional pain syndrome I and II ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. ...
Devices, Neurology, Product Launch
St. Jude Medical, dorsal root ganglion, Axium , Neurostimulator, DRG therapy

Profound Medical Corp., receives CE Mark Approval for TULSA-PRO(TM)

Mon, 04/11/2016 - 14:35
TORONTO, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- Profound Medical Corp. (“Profound” or “Company”) (PRN.V), a medical device company commercializing a unique and minimally invasive therapy in prostate care, today announced that the compa...
Devices, Urology, Regulatory
Profound Medical, TULSA-PRO, prostate, ablation

GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex

Mon, 04/11/2016 - 14:27
LONDON, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- GW Pharmaceuticals plc (GWPH) (GWP.L) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary ca...
Biopharmaceuticals, Neurology
GW Pharmaceuticals, Epidiolex, cannabidiol, Tuberous Sclerosis Complex

FDA Grants Priority Review for Genentech’s Cancer Immunotherapy Atezolizumab in Specific Type of Lung Cancer

Mon, 04/11/2016 - 12:49
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Applicat...
Biopharmaceuticals, Personalized Medicine, Oncology, FDA
Genentech, Roche Group, atezolizumab, NSCLC, Cancer Immunotherapy

Voluntary Recall of Fetch(TM) 2 Aspiration Catheter

Fri, 04/08/2016 - 21:41
MARLBOROUGH, Mass., April 8, 2016 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) has initiated a global, voluntary recall of all models of its Fetch™ 2 Aspiration Catheter, a thrombectomy catheter used during procedures to remo...
Devices, Interventional, Cardiology, Product Recall
Boston Scientific, Fetch 2, Aspiration Catheter, thrombectomy

Avion Pharmaceuticals, LLC, announces appointment of new Chief Executive Officer

Fri, 04/08/2016 - 15:09
ATLANTA, April 8, 2016 -- (Healthcare Sales & Marketing Network) -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, is pleased to announce the appointment of Harold A. Deas, Jr. as Chief Executive Officer. Mr. Deas, who will retain his rol...
Biopharmaceuticals, Dermatology, Personnel
Avion Pharmaceuticals

Eli Lilly and Company and AstraZeneca Announce Continuation of Pivotal Clinical Trial for People with Early Alzheimer's Disease

Fri, 04/08/2016 - 15:06
Phase 2/3 trial of AZD3293, an oral potent small molecule BACE inhibitor, will continue to Phase 3 after positive interim safety data INDIANAPOLIS, April 8, 2016 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (LLY) and AstraZeneca t...
Biopharmaceuticals, Neurology
Eli Lilly, AstraZeneca, beta secretase cleaving enzyme, Alzheimer's

Pharming Announces Adoption by the European Commission of the CHMP Recommendation to Change the Terms of the Marketing Authorisation for Ruconest(R)

Thu, 04/07/2016 - 15:28
TREATMENT OF HAE ATTACKS IN ADOLESCENTS WITH HAE APPROVED IGE TESTING REQUIREMENTS REMOVED LEIDEN, The Netherlands, April 7, 2016 -- (Healthcare Sales & Marketing Network) -- Pharming Group N.V. ("Pharming" or "the Company") (PHA...
Biopharmaceuticals, Regulatory
Pharming Group, RUCONEST, Hereditary Angioedema

PhaseBio Announces Leadership Team Appointments

Thu, 04/07/2016 - 15:24
John S. Lee, M.D., Ph.D., named Chief Medical Officer John P. Sharp, CPA, named Chief Financial Officer MALVERN, Pa., April 07, 2016 -- (Healthcare Sales & Marketing Network) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical comp...
Biopharmaceuticals, Cardiology, Personnel
PhaseBio Pharmaceuticals, elastin-like polypeptide

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

Thu, 04/07/2016 - 15:19
The new Trifecta™ Valve with Glide™ Technology provides enhanced valve delivery designed to improve implantation during both minimally invasive and conventional valve replacement procedures ST. PAUL, MN, April 7, 2016--(Healthcare Sales & Marketing Netw...
Devices, Cardiology, Product Launch
St. Jude Medical, Trifecta Valve, aortic valve

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong